PFE
Pfizer Inc
Pfizer Inc historical holders
total: 18
Parnassus Endeavor Fund Pfizer Inc transactions over time
- Total transactions:
- 4
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Held since:
- 2024 Q1
- Held for:
- 5 quarters
- Latest activity:
- 2025 Q2
Parnassus Endeavor Fund has been an institutional investor in Pfizer Inc (PFE) since 2024 Q1. According to 2026 Q2 report, Parnassus Endeavor Fund doesn't hold any shares. The fund/company first acquired PFE in 2024 Q1, initially purchasing about 3.19M shares. Since the initial investment, Parnassus Endeavor Fund has made 3 more transactions in this position.
When did Parnassus Endeavor Fund exit their PFE position?
Parnassus Endeavor Fund no longer holds Pfizer Inc (PFE). They sold off their entire position in 2025 Q2, closing out an investment that began in 2024 Q1.
When did Parnassus Endeavor Fund first invest in PFE?
Parnassus Endeavor Fund first invested in Pfizer Inc (PFE) in 2024 Q1 at the reported quarter-end price of $27.75 per share, acquiring 3,185,839 shares in their initial purchase.
What is Parnassus Endeavor Fund's average cost basis for PFE?
Based on historical transaction data, Parnassus Endeavor Fund's estimated cost basis for Pfizer Inc (PFE) is approximately $27.85 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $27.85
- Weighted AVG sell price:
- $25.34
PFE transactions history by Parnassus Endeavor Fund
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q2
|
0.00%
|
0
|
$25.34
|
|
-100% (-4,390,705)
|
-2.48%
|
|
2024 Q3
|
2.51%
|
4,390,705
|
$28.94
|
$127,067,003
|
+3.71% (+156,894)
|
+0.09%
|
|
2024 Q2
|
2.42%
|
4,233,811
|
$27.98
|
$118,462,032
|
+32.89% (+1,047,972)
|
+0.6%
|
|
2024 Q1
|
1.69%
|
3,185,839
|
$27.75
|
$88,407,032
|
new
|
+1.69%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.